113 related articles for article (PubMed ID: 14558405)
1. Rosacea fulminans associated with pegylated interferon alpha-2B and ribavirin therapy.
Jensen SL; Holmes R
J Drugs Dermatol; 2003 Oct; 2(5):554-6. PubMed ID: 14558405
[TBL] [Abstract][Full Text] [Related]
2. Rosacea fulminans related to pegylated interferon alpha-2b and ribavirin therapy.
Bettoli V; Mantovani L; Boccia S; Virgili A
Acta Derm Venereol; 2006; 86(3):258-9. PubMed ID: 16710591
[No Abstract] [Full Text] [Related]
3. Catatonia associated with pegylated interferon-α 2b and ribavirin for hepatitis C.
Quinn D; Kuchler E; Deming P; Arora S
Psychosomatics; 2012; 53(4):400-1. PubMed ID: 22748752
[No Abstract] [Full Text] [Related]
4. Pegylated interferon and ribavirin therapy for hepatitis C causing cataract.
Ku JY; Sharma A
Clin Exp Ophthalmol; 2009 Sep; 37(7):743-5. PubMed ID: 19788675
[No Abstract] [Full Text] [Related]
5. Reversible decompensated liver disease as a possible complication of pegylated-interferon alfa 2b and ribavirin for recurrent hepatitis C.
Mukherjee S
J Gastroenterol Hepatol; 2004 Jun; 19(6):723-4. PubMed ID: 15151639
[No Abstract] [Full Text] [Related]
6. Adult respiratory distress syndrome after treatment with pegylated interferon alpha-2a and ribavirin.
Vartany E; Caldwell CA; Trow TK
Heart Lung; 2008; 37(2):153-6. PubMed ID: 18371508
[TBL] [Abstract][Full Text] [Related]
7. Adverse skin reactions due to pegylated interferon alpha 2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus.
Hashimoto Y; Kanto H; Itoh M
J Dermatol; 2007 Aug; 34(8):577-82. PubMed ID: 17683392
[TBL] [Abstract][Full Text] [Related]
8. Rhabdomyolysis associated with the co-administration of daptomycin and pegylated interferon α-2b and ribavirin in a patient with hepatitis C.
Colomba C; Rubino R; Siracusa L; Mazzola G; Titone L
J Antimicrob Chemother; 2012 Jan; 67(1):249-50. PubMed ID: 21965434
[No Abstract] [Full Text] [Related]
9. Lingual hyperpigmentation with pegylated interferon and ribavirin therapy in patients with chronic hepatitis C.
Sood A; Midha V; Bansal M; Goyal A; Sharma N
Indian J Gastroenterol; 2006; 25(6):324. PubMed ID: 17264447
[No Abstract] [Full Text] [Related]
10. [Healing hepatitis C infections. Pegylated interferon alfa-2a opens new perspectives].
MMW Fortschr Med; 2003 Jun; 145(26):52-3. PubMed ID: 12916339
[No Abstract] [Full Text] [Related]
11. Severe interstitial pneumonitis secondary to pegylated interferon alpha-2b and ribavirin treatment of hepatitis C infection.
Fuhrmann V; Kramer L; Bauer E; Laferl H; Tucek G; Dekan G; Schenk P
Dig Dis Sci; 2004; 49(11-12):1966-70. PubMed ID: 15628735
[No Abstract] [Full Text] [Related]
12. [Cutaneous reactions induced by pegylated-interferon plus ribavirin combination therapy in a patient with chronic hepatitis C].
Enjoji M; Dainichi T; Gondo H; Urabe K
Fukuoka Igaku Zasshi; 2007 Sep; 98(9):353-6. PubMed ID: 17974079
[TBL] [Abstract][Full Text] [Related]
13. [Hepatitis C therapy is not pleasant. Patients must be prepared!].
MMW Fortschr Med; 2003 Jan; 145(3-4):57. PubMed ID: 12619237
[No Abstract] [Full Text] [Related]
14. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
Rogers CJ; Romagosa R; Vincek V
J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
[No Abstract] [Full Text] [Related]
15. Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation.
Castells L; Vargas V; Allende H; Bilbao I; Luis Lázaro J; Margarit C; Esteban R; Guardia J
J Hepatol; 2005 Jul; 43(1):53-9. PubMed ID: 15876467
[TBL] [Abstract][Full Text] [Related]
16. A case of exacerbation of ulcerative colitis induced by combination therapy with PEG-interferon alpha-2b and ribavirin.
Watanabe T; Inoue M; Harada K; Homma N; Uchida M; Ogata N; Funada R; Hasegawa K; Soga K; Shibasaki K
Gut; 2006 Nov; 55(11):1682-3. PubMed ID: 17047132
[No Abstract] [Full Text] [Related]
17. Crohn's disease onset in an HIV/hepatitis C virus co-infected woman taking pegylated interferon alpha-2b plus ribavirin.
Bongiovanni M; Ranieri R; Ferrero S; Casanova F; Monforte Ad
AIDS; 2006 Oct; 20(15):1989-90. PubMed ID: 16988527
[No Abstract] [Full Text] [Related]
18. [Adverse effects of combining polyethylene glycol interferon with ribavilin on hepatitis C patients].
Si CW
Zhonghua Gan Zang Bing Za Zhi; 2003 Nov; 11(11):686-7. PubMed ID: 14636449
[No Abstract] [Full Text] [Related]
19. Incidence of psychiatric side effects during pegylated interferon- alpha retreatment in nonresponder hepatitis C virus-infected patients.
Quarantini LC; Bressan RA; Galvão A; Batista-Neves S; Paraná R; Miranda-Scippa A
Liver Int; 2007 Oct; 27(8):1098-102. PubMed ID: 17845538
[TBL] [Abstract][Full Text] [Related]
20. Hashimoto encephalopathy with pegylated interferon alfa-2b and ribavirin.
Deutsch M; Koskinas J; Tzannos K; Vassilopoulos D; Mailis A; Tolis G; Hadziyannis S
Ann Pharmacother; 2005 Oct; 39(10):1745-8. PubMed ID: 16159996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]